CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Reports

We found 127 result(s)

cabotegravir/rilpivirine (Vocabria and Cabenuva)

Last Updated: September 17, 2020
Result type: Reports
Product Line: Reimbursement Review
Generic Name: cabotegravir sodium cabotegravir-rilpivirine
Indications: HIV-1 infection

  • Brand Name: Vocabria and Cabenuva
  • Manufacturer: ViiV Healthcare ULC
  • Project Number: SR0628-000
  • Project Status: Complete
  • Submission Type: Initial

Health Technology Update Issue 26

Last Updated: June 12, 2020
Result type: Reports
Product Line: Health Technology Update

This issue of Health Technology Update features brief summaries of information on a broad range of medical technologies — from a robotic wheelchair that uses gyroscope technology to a self-expanding pulmonary valve . These technologies were identified through the CADTH Horizon Scanning Service as topics potentially of interest to Canadian health...

  • Project Number: EN0016-000

Health Technology Update Issue 27

Last Updated: May 20, 2020
Result type: Reports
Product Line: Health Technology Update

This issue of Health Technology Update features brief summaries of information on a range of technologies that aim to support the prevention, identification, and management of COVID-19 — from smartphone apps for contact tracing to self-collected sampling for diagnostic testing. These technologies were identified through the CADTH Horizon Scannin...

  • Project Number: EN0017-000